dr-dupont

Qualifications

Qualifications:

MB BCh BAO (Hons) LRCSI LRCPI MRCPI DIC PhD FRCPI

Year qualified:

1993

Country of qualification:

Ireland

Registration & Memberships

Registration and licensing

  • Full

Memberships and associations

  • Renal Association
  • British Transplantation Society
  • The Transplantation Society

Languages Spoken

  • English

Dr Peter John Dupont

Consultant Nephrologist

MB BCh BAO (Hons) LRCSI LRCPI MRCPI DIC PhD FRCPI

Dr Dupont qualified from the RCSI Medical School, Dublin in 1993. He trained in Nephrology on the North Thames specialty training scheme and completed a PhD in transplantation immunology at Imperial College London, Hammersmith Hospital in 2005. He was appointed Consultant Nephrologist/Honorary Senior Lecturer at the Royal Free Hospital, London in 2006 and became a Fellow of the Royal College of Physicians in Ireland in 2008. He is dual accredited in Renal and General Internal Medicine.

Dr Dupont has a subspecialty interest in renal transplantation including pre-transplant assessment, infectious complications of transplantation and management of chronic allograft dysfunction. He is principal investigator for a number of clinical trials in renal transplantation. Dr Dupont is member of the Renal Association, British Transplantation Society and the London Transplant Research Network.

Dr Dupont’s NHS practice encompasses all aspects of general nephrology including investigation and management of acute and acute and chronic kidney disease along with difficult hypertension.

Specialities:

Nephrology

Procedures offered:

Renal biopsy

Haemodialysis

Peritoneal dialysis

Clinical Interests:

General nephrology

Hypertension

Chronic kidney disease

Renal transplantation

Haemodialysis

Peritoneal dialysis

Research interests:

Transplantation Immunology

Infectious and other complications of renal transplantation

Chronic transplant rejection

Published papers:

Power A, Dupont P. Pre-transplant Assessment. In: Practical Nephrology edited by Harber, Springer 2014.

Stephens H, Dupont P, Harber M. Tissue-typing, crossmatch and antibody incompatibility in renal transplantation. In Practical Nephrology edited by Harber. Springer 2014.

Rahman H, Dupont P, Cohen M, Vancheeswaran R. A case of profound hypercalcaemia and acute kidney injury. BMJ 2013;347:f6744

Caplin B, Veighey K, Mahenderan A, Manook M, Henry J, Nitsch D, Harber M, Dupont P, Wheeler DC, Jones G, Fernando B, Howie AJ, Veitch P. Early changes in scores of chronic damage on transplant kidney protocol biopsies reflect donor characteristics, but not future graft function. Clin Transplant. 2013; 27:669-78.

Cheung K, Pencharz D, Jeetly P, Jones G, Dupont P, Hall M. Diagnostic and Prognostic Value of Myocardial Perfusion Scintigraphy and Stress Echocardiography in Renal Transplant Recipients: A Retrospective Study. Eur J Nucl Med Mol Imaging 2012;39:S421.

Arulkumaran N, Reitbock P, Halliday K, Onwubalili J, Jayasena D, Dupont P. Adult-onset Still’s disease associated with collapsing glomerulopathy. NDT Plus 2010;3(1):54-6.

Dupont P, Manuel O, Pascual M. Infection and chronic allograft dysfunction. Kidney International 2010; 78 (Suppl 119): S47–S53.

Dupont P, Psimenou E, Buscombe JR, Hilson AJ, Sweny P. Recurrent urinary tract infection in the late post-transplant period may produce renal allograft scarring even in the absence of symptoms or overt vesico-ureteric reflux. Transplantation. 2007; 84:351-5.

Dupont P, Warrens AN. Fas ligand exerts its pro-inflammatory effects via neutrophil recruitment but not activation. Immunology 2007; 120:133-9.

Saini T, McKinnon M, Dupont P, Hatfield P, Saunders Y. A comparative study of symptoms and quality of life in cancer patients and patients with end stage renal disease. Palliative Medicine 2006; 20:631-6.

Dooldeniya MD, Dupont P, Joshi T, Basra R, He X, Johnston A, Warrens AN. Renal transplantation in Indo-Asian patients in the UK. American Journal of Transplantation 2006; 6:761-9.

Little MA, Dupont P, Campbell E, Dorman A, Walshe JJ. Severity of primary MPGN, rather than MPGN type determines renal survival and post-transplantation recurrence risk. Kidney International 2006; 69:504-11.

Griffiths E, Nelson R, Dupont P, Warrens AN. Skewing of anti-HLA antibodies solely towards the IgG1 subclass is associated with poorer renal allograft survival. Transplantation 2004; 77:1771-3.

Dupont P, Warrens AN. The evolving role of sirolimus in renal transplantation. QJM 2003; 96:401-409.

Dupont P, Dooldeniya M, Cook T, Warrens AN. Role of duplex Doppler sonography in diagnosis of acute allograft dysfunction – time to stop measuring the resistive index? Transplant International 2003; 16:648-52.

Dupont P, Hunt I, Goldberg L, Warrens AN. Colchicine myoneuropathy in a renal transplant recipient. Transplant International 2002 15:374-6.

Dupont P, Warrens AN. Cholesterol emboli syndrome – a review. Journal of the Irish Colleges of Physicians and Surgeons 2001; 30:219-222.

Dupont P, Jackson J, Warrens A, Lightstone L. Life threatening thrombosis eighteen years after first presentation of primary antiphospholipid antibody syndrome. Nephrology, Dialysis and Transplantation 2001; 16:843-845.

Dupont P, Thornton J. Near-fatal gammabutyrolactone intoxication – first report in the UK. Human & Experimental Toxicology 2001; 20:19-22.

Dupont P, Lightstone L, Gaskin G, Clutterbuck E, Pusey CD, Cook T, Warrens AN. Cholesterol emboli syndrome. BMJ 2000; 321:1065-67.

Oomatia A, Dupont P, Bass P, Moochhala S. Shining a light on an unusual case of CKD. Kidney International 2017 (in press).

Dr Peter John Dupont, Consultant Nephrologist, is available to be seen for consultations at the Royal Free.